NDVR Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$544K Buy
506
+106
+27% +$101K 0.45% 23
2025
Q3
$305K Buy
400
+97
+32% +$72.2K 0.25% 60
2025
Q2
$236K Sell
303
-25
-8% -$19.4K 0.22% 92
2025
Q1
$271K Sell
328
-7
-2% -$5.83K 0.28% 65
2024
Q4
$259K Buy
335
+56
+20% +$46.4K 0.25% 71
2024
Q3
$245K Sell
279
-24
-8% -$21.6K 0.25% 69
2024
Q2
$274K Buy
+303
New +$242K 0.29% 46

Other funds holding LLY

NDVR Inc's LLY Position: Q4 2025 in Review

NDVR Inc increased its Eli Lilly (LLY) stake by 27% in Q4 2025, buying an estimated $101K and bringing the position to 506 shares worth $544K. The position accounts for 0.45% of the portfolio, ranked #23.

NDVR Inc first reported a position in LLY in Q2 2024 and has held it in 7 quarters since. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • NDVR Inc held 506 shares of Eli Lilly worth $544K as of Q4 2025.
  • NDVR Inc bought 106 Eli Lilly shares in Q4 2025, an estimated $101K.
  • Eli Lilly made up 0.45% of NDVR Inc's portfolio in Q4 2025, its #23 holding.
  • NDVR Inc first reported a position in Eli Lilly in Q2 2024 and has held it in 7 quarters since.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on NDVR Inc's 13F filing for Q4 2025, filed 12 Feb 2026.